Merck & Co. (NYSE:MRK) is cashing in on the meteoric rise of Moderna Inc. (NASDAQ:MRNA) in 2020 after the pharmaceutical giant dumped its equity stake in Moderna. Since the beginning of this year, Moderna, which is developing a potential COVID-19 vaccine, has gained over 620%. Merck sells its stake in […]
